Biomaterials

Biomaterials Market Value is Estimated to be US$ 390.92 Bn by 2027

SHARE THIS ARTICLE

According to the new report “Biomaterials Market Size, Share, & Growth Analysis Report By Product (Metallic, Ceramics, Natural, and Polymers) By Application (Ophthalmology, Cardiovascular, Dental, Wound Healing, Orthopedic, Plastic Surgery, Tissue Engineering, Neurology, and Others) – Global Industry Analysis, Trends, Regional Outlook and Forecasts 2020 – 2027″, the biomaterials market value is projected to hit around US$ 390.92 billion by 2027, registering a CAGR of 15.2% from 2020 to 2027.

The report provides the overall revenue of the global biomaterials market from 2016 to 2027, considering 2020 as the base year and 2027 as the forecast year.

Growth Factors

The government of various regions along with universities researching on medical sector has allocated funds for the development of novel biomaterials. The aforementioned factor expected to drive the market growth. For instance, two European Commission programs allotted USD 15.6 Billion for research on biomaterials for a period of five years from 2013 to 2017. Similarly, in March 2018, Drexel University issued USD 200,000 to the National Science Foundation for researching on how biomaterial vascularization gets affected from the biomaterial-mediated control over macrophage behavior.

However, in various regions such as Asia Pacific, Europe, and North America, government has stringent regulations for the application of biomaterial-based medical devices to ensure their efficacy and quality. The above mentioned factor expected to hamper the market growth in the coming years.

We customize your report according to your research need. REQUEST CUSTOMIZED COPY OF REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1059

Report Highlights

  • In 2019, North America led the global biomaterials market due to initiatives taken by different private and public organizations. Furthermore, increasing number of surgeries along with the presence of numerous market players in the region account for the significant growth of the market.
  • The Asia Pacific anticipated witnessing the fastest growth during the analysis period. This is attributed to the major strategies adopted by the regional players to reinforce their presence in both global as well as regional market.
  • Based on product, polymer segment led the global biomaterials market with considerable revenue share in 2019 and projected to continue its dominance in the coming years. This is mainly attributed to the wide range of applications of polymer products. Besides this, natural biomaterials anticipated to register the highest growth rate over the forecast period due to numerous benefits offered by the product over synthetic biomaterials related to biocompatibility, biodegradability, and remodeling.
  • By application, the orthopedic segment captured maximum revenue share in the global biomaterials market in 2019. Rising adoption of metallic biomaterials owing to their high load bearing capacity is one of the prime factors that drive the growth of the segment. Besides this, significant developments and on-going investments for the advancement in orthopedic implants by market participants are Moreover, plastic surgery analyzed to grow at a significant pace during the forecast period owing to increasing number of cosmetic procedures along with significant application of biomaterials in such surgeries. likely to propel the market growth in the next years to come.

Regional Snapshots

In 2019, North America accounted for the maximum revenue share in the global biomaterials market. This is mainly due to significant growth in the number of surgeries in the region along with application of biomaterials in those surgeries. According to the stats presented by American Society of Plastic Surgeons (ASPS), nearly 18 Million people in the United States have undergone surgical or minimally invasive cosmetic procedures in the year 2018.

However, the Asia Pacific registered the fastest growth rate over the forecast period. Factors attributed to the prominent growth of the biomaterials market in the Asia Pacific region include rapid growth of healthcare industry in Japan, rising cosmetic & plastic surgeries, increasing geriatric population, increasing cases of knee & hip replacement procedures, rising prevalence of cardiovascular diseases, and growing research activities.

Key Players & Strategies

The global biomaterials market is highly competitive due to the presence of numerous regional as well as international players along with significant investments from these market participants to expand their presence. In addition, the market vendors adopt inorganic growth strategies such as partnerships, agreements, collaboration, and merger & acquisition to strengthen their product portfolio. Product development is the fundamental strategy that every market players adopt and invest prominently to expand their offerings. For instance, in October 2019, Evonik Industries launched its bio-resorbable PLA-PEG copolymers, which are designed to be used in implantable medical devices. The product development improved the safety, biocompatibility, and performance of implantable products that are used by medical device customers.

Some of the key players operating in the market are Evonik Industries AG, Medtronic plc, Berkeley Advanced Biomaterials, Corbion, Carpenter Technology Corporation, Zimmer Biomet Holdings, Inc., Invibio Ltd., Covalon Technologies Ltd., BASF SE, Johnson & Johnson, Stryker Corporation, CoorsTek Inc., DentsplySirona, and Collagen Matrix, Inc.among others.

Segments Covered in the Report 

This research study encompasses comprehensive assessment of the marketplace revenue with the help of prevalent quantitative and qualitative intelligences, and prognoses of the market. This report presents breakdown of market into major and niche segments. Furthermore, this research study gauges market revenue growth and its drift at global, regional, and country from 2016 to 2027. This report comprises market division and its revenue valuation by categorizing it depending on product, application, and region:

By Product

  • Metallic
  • Ceramics
  • Natural
  • Polymers

By Application

  • Ophthalmology
    • Intraocular Lens
    • Synthetic Corneas
    • Ocular Tissue Replacement
    • Others
  • Cardiovascular
    • Stents
    • Sensors
    • Implantable Cardiac Defibrillators
    • Guidewires
    • Vascular Grafts
    • Pacemakers
    • Others
  • Dental
    • Dental Implants
    • Tissue Regeneration Materials
    • Bone Grafts & Substitutes
    • Others
  • Wound Healing
    • Adhesion Barrier
    • Surgical Hemostats
    • Fracture Healing Device
    • Internal Tissue Sealant
    • Skin Substitutes
    • Others
  • Orthopedic
    • Orthobiologics
    • Joint Replacement Biomaterials
    • Viscosupplementation
    • Spine Biomaterials
    • Bioresorbable Tissue Fixation Products
    • Others
  • Plastic Surgery
    • Soft Tissue Fillers
    • Facial Wrinkle Treatment
    • Bioengineered Skins
    • Craniofacial Surgery
    • Acellular Dermal Matrices
    • Peripheral Nerve Repair
    • Others
  • Tissue Engineering
  • Neurology
    • Shunting Systems
    • Neural Stem Cell Encapsulation
    • Cortical Neural Prosthetics
    • Hydrogel Scaffold For CNS Repair
    • Others
  • Others

By Regional Outlook

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Biomaterials Market, By Product

7.1. Biomaterials Market, by Product Type, 2020-2027
7.1.1. Metallic
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Ceramics
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Natural
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Polymers
7.1.4.1. Market Revenue and Forecast (2016-2027)

Chapter 8. Global Biomaterials Market, By Application

8.1. Biomaterials Market, by Application, 2020-2027
8.1.1.1. Ophthalmology
8.1.1.2. Market Revenue and Forecast (2016-2027)
8.1.1.3. Cardiovascular
8.1.1.4. Market Revenue and Forecast (2016-2027)
8.1.2. Dental
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Wound Healing
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Orthopedic
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Plastic Surgery
8.1.5.1. Market Revenue and Forecast (2016-2027)
8.1.6. Tissue Engineering
8.1.6.1. Market Revenue and Forecast (2016-2027)
8.1.7. Neurology
8.1.7.1. Market Revenue and Forecast (2016-2027)
8.1.8. Others
8.1.8.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global Biomaterials Market, Regional Estimates and Trend Forecast

9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2016-2027)
9.1.2. Market Revenue and Forecast, by Application (2016-2027)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Product (2016-2027)
9.1.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Product (2016-2027)
9.1.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2016-2027)
9.2.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Product (2016-2027)
9.2.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Product (2016-2027)
9.2.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Product (2016-2027)
9.2.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Product (2016-2027)
9.2.6.2. Market Revenue and Forecast, by Application (2016-2027)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2016-2027)
9.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Product (2016-2027)
9.3.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Product (2016-2027)
9.3.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Product (2016-2027)
9.3.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Product (2016-2027)
9.3.6.2. Market Revenue and Forecast, by Application (2016-2027)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2016-2027)
9.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Product (2016-2027)
9.4.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Product (2016-2027)
9.4.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Product (2016-2027)
9.4.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Product (2016-2027)
9.4.6.2. Market Revenue and Forecast, by Application (2016-2027)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2016-2027)
9.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Product (2016-2027)
9.5.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Product (2016-2027)
9.5.4.2. Market Revenue and Forecast, by Application (2016-2027)

Chapter 10. Company Profiles

10.1. Evonik Industries AG
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Medtronic plc
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Berkeley Advanced Biomaterials
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Corbion
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Carpenter Technology Corporation
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Zimmer Biomet Holdings, Inc.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Invibio Ltd.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Covalon Technologies Ltd.
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. BASF SE
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Johnson & Johnson
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
10.11. Stryker Corporation
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives
10.12. CoorsTek Inc.
10.12.1. Company Overview
10.12.2. Product Offerings
10.12.3. Financial Performance
10.12.4. Recent Initiatives
10.13. DentsplySirona
10.13.1. Company Overview
10.13.2. Product Offerings
10.13.3. Financial Performance
10.13.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions

Chapter 12. Appendix

12.1. About Us
12.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Why Buy this Report?

The purpose of Precedence Research’s biomaterials market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.

Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1059

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Follow us on LinkedIn | Twitter | Facebook

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. Email: sales@flairinsight.com

View all posts by Precedence Research →

Leave a Reply

Your email address will not be published. Required fields are marked *